Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: Russia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20112
20121
20161
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AO GENERIUM1
Accenture1
Ascenta Therapeutics1
Eisai Inc.1
Halozyme Therapeutics1
Janssen Research & Development, LLC1
Pfizer1
Tomsk National Research Medical Center of the Russian Academy of Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms8
Adenocarcinoma1
Hematologic Diseases1
Immune System Diseases1
Immunoproliferative Disorders1
Leukemia1
Leukemia, Lymphoid1
Lymphatic Diseases1
Lymphoproliferative Disorders1
Neoplasms by Histologic Type1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.